Gene · 717
Papers2,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complement C1q and C2 polymorphisms are not risk factors for SLE in Indian Tamils. | Immunobiology | 2014 | 24629783 | PubTator, text mining | PubMed |
| A bifunctional protein regulates mitochondrial protein synthesis. | Nucleic Acids Res | 2014 | 24598254 | PubTator, text mining | PubMed |
| Complement C3, C2, and factor B gene polymorphisms and age-related macular degeneration in a Greek cohort study. | Eur J Ophthalmol | 2014 | 24519512 | PubTator, text mining | PubMed |
| Renal manifestations of genetic mitochondrial disease. | Int J Nephrol Renovasc Dis | 2014 | 24516335 | PubTator, text mining | PubMed |
| Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targets. | Cancer Lett | 2014 | 24486220 | PubTator, text mining | PubMed |
| Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. | JAMA Ophthalmol | 2014 | 24481424 | PubTator, text mining | PubMed |
| CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans. | Mol Vis | 2014 | 24453474 | PubTator, text mining | PubMed |
| PSP toxins profile in ascidian Microcosmus vulgaris (Heller, 1877) after human poisoning in Croatia (Adriatic Sea). | Toxicon | 2014 | 24418175 | PubTator, text mining | PubMed |
Qualitative and quantitative characterization of plasma proteins when incorporating traveling wave ion mobility into a liquid chromatography-mass spectrometry workflow for biomarker discovery: use of product ion quantitation as an alternative data analysis tool for label free quantitation. | Anal Chem | 2014 | 24397486 | PubTator, text mining | PubMed |
| Proteomic analysis of SP600125-controlled TrkA-dependent targets in SK-N-MC neuroblastoma cells: inhibition of TrkA activity by SP600125. | Proteomics | 2014 | 24375967 | PubTator, text mining | PubMed |
| Nature and nurture- genes and environment- predict onset and progression of macular degeneration. | Prog Retin Eye Res | 2014 | 24374240 | PubTator, text mining | PubMed |
| Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells. | Mol Biosyst | 2014 | 24292090 | PubTator, text mining | PubMed |
| Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. | Ophthalmology | 2014 | 24289920 | PubTator, text mining | PubMed |
| Viral subversion of nucleocytoplasmic trafficking. | Traffic | 2014 | 24289861 | PubTator, text mining | PubMed |
| Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies. | JAMA Ophthalmol | 2014 | 24287500 | PubTator, text mining | PubMed |
| An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. | J Proteomics | 2014 | 24275569 | Swiss-Prot, curated | PubMed |
| The role of complement in tumor growth. | Adv Exp Med Biol | 2014 | 24272362 | PubTator, text mining | PubMed |
| Expression and purification methods for the production of recombinant human complement component C2. | Methods Mol Biol | 2014 | 24218250 | PubTator, text mining | PubMed |
| Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases. | Biochim Biophys Acta | 2014 | 24200652 | PubTator, text mining | PubMed |
| Operative nuances to safeguard anomalous vertebral artery without compromising the surgery for congenital atlantoaxial dislocation: untying a tough knot between vessel and bone. | J Neurosurg Spine | 2014 | 24180313 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/717/papers?page=48